We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
6530 Background: Dasatinib is a dual Src-Abl kinase inhibitor which is 300 fold more potent than imatinib and 20-fold more potent than AMN107 (a selective potent Bcr-Abl kinase inhibitor). Dasatinib also inhibits Src which may overcome CML resistance. METHODS Study Aims: To report the experience with dasatinib in patients who develop CML failure post(More)
Collaborative Information Retrieval (CIR) is the process by which people search for and retrieve information, typically using documents as data sources. Shared computing surfaces that utilise multi-touch interaction can allow multiple users to interact around a shared display. This paper describes the design and evaluation of a prototype system to support(More)
  • 1